Company Search:
Advanced Search
Sponsored Links
Sam Chun Dang Pharm Co Ltd Company Snapshot
Sam Chun Dang Pharm Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sam Chun Dang Pharm Co Ltd with three other companies in this sector in South Korea: Whanin Pharmaceutical Company Limited (2017 sales of 147.95 billion Korean Won [US$131.38 million] of which 78% was Riperidon &Quetapin etc.), Bukwang Pharmaceutical Company Limited (150.74 billion Korean Won [US$133.86 million] of which 100% was Pharmacy), and JW Life Science Corp (143.60 billion Korean Won [US$127.52 million] ).

Sales Analysis. Sam Chun Dang Pharm Co Ltd reported sales of 161.11 billion Korean Won (US$143.07 million) for the year ending December of 2017. This represents an increase of 9.3% versus 2016, when the company's sales were 147.37 billion Korean Won. Sales at Sam Chun Dang Pharm Co Ltd have increased during each of the previous five years (and since 2012, sales have increased a total of 110%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Sam Chun Dang Pharm Co Ltd
  Stock Performance Chart for Sam Chun Dang Pharm Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 47,950
(Figures in Korean Won)
1 Week 1.6%   13 Weeks 28.9%  
4 Weeks 26.4%   52 Weeks 22.5%  
Sam Chun Dang Pharm Co Ltd Key Data:
  Ticker: 000250 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 161,111,597,304
(Year Ending Jan 2018).
Employees: 364
  Currency: Korean Won Market Cap: 1,026,408,733,350
  Fiscal Yr Ends: December Shares Outstanding: 21,405,813
  Share Type: Common Closely Held Shares: 8,457,218
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.